학술논문
Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia major
Document Type
Article
Author
Source
In: Haematologica . (Haematologica, 1 June 2012, 97(6):842-848)
Subject
Language
English
ISSN
03906078
15928721
15928721